Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
Brain
    September 2025
  1. FURLAN R, Schaedelin S, Frederiksen JL, Watanabe M, et al
    Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.
    Brain. 2025 Sep 24:awaf345. doi: 10.1093.
    >> Share

  2. ESSER D, Muller-Miny L, Heming M, Paunovic M, et al
    Activated alphabeta T and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis.
    Brain. 2025;148:3170-3183.
    >> Share

    August 2025
  3. PAPE K, Hanuscheck N, Schmaul S, Kneilmann F, et al
    Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis.
    Brain. 2025 Aug 25:awaf268. doi: 10.1093.
    >> Share

  4. RODRIGUES P, Frare JM, Ruviaro NA, Peres DS, et al
    Advanced oxidation protein products activated TRPA1 in a neuropathic multiple sclerosis model.
    Brain. 2025 Aug 17:awaf306. doi: 10.1093.
    >> Share

  5. CHIEK TEOH CS, Dubey SG, Handel AE
    Rethinking corticosteroid therapy in autoimmune neurology.
    Brain. 2025 Aug 11:awaf292. doi: 10.1093.
    >> Share

  6. KALINCIK T, Sharmin S, Roos I, Freedman MS, et al
    Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.
    Brain. 2025 Aug 4:awaf286. doi: 10.1093.
    >> Share

  7. ABDELHAK A, Cordano C, Duncan GJ, Emberley K, et al
    Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination.
    Brain. 2025;148:3011-3020.
    >> Share

  8. NISHIGORI R, Hamatani M, Yoshitomi H, Kimura K, et al
    CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica.
    Brain. 2025;148:2995-3010.
    >> Share

    June 2025
  9. CUNNIFFE NG
    Extending the role of neurofilament light in multiple sclerosis beyond measuring irreversible neurodegeneration.
    Brain. 2025 Jun 9:awaf224. doi: 10.1093.
    >> Share

  10. MAUDES E, Planaguma J, Marmolejo L, Radosevic M, et al
    Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis.
    Brain. 2025;148:2023-2037.
    >> Share

    May 2025
  11. IRANI SR
    Models of autoantibody mediated diseases: actively nearing the human gold standard.
    Brain. 2025 May 23:awaf160. doi: 10.1093.
    >> Share

  12. FENG YF, Zeng ZK, Ni Y, Hu Y, et al
    Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis.
    Brain. 2025;148:1652-1664.
    >> Share

  13. GIOVANNONI G, James L, Adeniran AA, Gold J, et al
    The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.
    Brain. 2025 May 6:awaf170. doi: 10.1093.
    >> Share

    April 2025
  14. NOBILE-ORAZIO E, Cocito D, Manganelli F, Fazio R, et al
    Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trial.
    Brain. 2025;148:1112-1121.
    >> Share

    March 2025
  15. THOMMA RCM, Halstead SK, de Koning LC, Wiegers EEJA, et al
    Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barre syndrome.
    Brain. 2025 Mar 17:awaf102. doi: 10.1093.
    >> Share

    January 2025
  16. GIOVANNONI G
    EBV-specific T-cell responses are telling us something important about multiple sclerosis.
    Brain. 2025 Jan 27:awaf027. doi: 10.1093.
    >> Share

    December 2024
  17. CHEN JQA, McNamara NB, Engelenburg HJ, Jongejan A, et al
    Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis.
    Brain. 2024 Dec 24:awae414. doi: 10.1093.
    >> Share

  18. ANDRODIAS G, Lunemann JD, Maillart E, Amato MP, et al
    De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.
    Brain. 2024 Dec 21:awae409. doi: 10.1093.
    >> Share

  19. COLES A
    A blood test to predict prognosis in multiple sclerosis?
    Brain. 2024;147:3969.
    >> Share

    November 2024
  20. SUN J, Guo M, Chai L, Xu S, et al
    Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases.
    Brain. 2024;147:3906-3917.
    >> Share

    September 2024
  21. BERGNER CG, van der Meer F, Franz J, Vakrakou A, et al
    BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis.
    Brain. 2024 Sep 25:awae293. doi: 10.1093.
    >> Share

    August 2024
  22. MONREAL E, Fernandez-Velasco JI, Alvarez-Lafuente R, Sainz de la Maza S, et al
    Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.
    Brain. 2024 Aug 5:awae260. doi: 10.1093.
    >> Share

  23. ZHAO M, Lynch DR, Irani SR
    Autoimmune 'secondary synaptopathies': do NMDAR antibodies cause a primary extra-synaptopathy?
    Brain. 2024;147:2601-2603.
    >> Share

    July 2024
  24. FILIPPI M, Preziosa P, Barkhof F, Ciccarelli O, et al
    The ageing central nervous system in multiple sclerosis: the imaging perspective.
    Brain. 2024 Jul 24:awae251. doi: 10.1093.
    >> Share

  25. HOLM RP, Wandall-Holm MF, Magyari M
    Multiple sclerosis in Denmark (1950-2023): mean age, sex distribution, incidence and prevalence.
    Brain. 2024 Jul 20:awae245. doi: 10.1093.
    >> Share

  26. TAYLOR BV, Ponsonby AL, Stein M, Lucas R, et al
    Reply: Putative benefits of vitamin D supplements in multiple sclerosis out of reach due to sample size.
    Brain. 2024 Jul 19:awae246. doi: 10.1093.
    >> Share

  27. SCHNEIDER-HOHENDORF T, Wunsch C, Falk S, Raposo C, et al
    Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation.
    Brain. 2024 Jul 18:awae244. doi: 10.1093.
    >> Share

  28. CORSTEN CEA, Wokke BHA, Smolders J
    Putative benefits of vitamin D supplements in multiple sclerosis out of reach due to sample size.
    Brain. 2024 Jul 16:awae238. doi: 10.1093.
    >> Share

    May 2024
  29. JAMET Z, Mergaux C, Meras M, Bouchet D, et al
    NMDA receptor autoantibodies primarily impair the extrasynaptic compartment.
    Brain. 2024 May 17:awae163. doi: 10.1093.
    >> Share

    April 2024
  30. HUANG J, Tengvall K, Bomfim Lima I, Hedstrom AK, et al
    Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Brain. 2024 Apr 17:awae110. doi: 10.1093.
    >> Share

  31. ARELLANO G, Loda E, Chen Y, Neef T, et al
    Interferon-gamma controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder.
    Brain. 2024;147:1344-1361.
    >> Share

    March 2024
  32. MAINERO C, Miscioscia A, Treaba CA
    Cortical remyelination in multiple sclerosis: a target for disease monitoring and intervention.
    Brain. 2024 Mar 27:awae083. doi: 10.1093.
    >> Share

    January 2024
  33. HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al
    Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Brain. 2024 Jan 30:awae030. doi: 10.1093.
    >> Share

  34. LAZZAROTTO A, Hamzaoui M, Tonietto M, Dubessy AL, et al
    Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
    Brain. 2024 Jan 24:awae024. doi: 10.1093.
    >> Share

  35. BAGNATO F, Sati P, Hemond CC, Elliott C, et al
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain. 2024 Jan 16:awae013. doi: 10.1093.
    >> Share

  36. SCHWAB N
    Transcriptomics reveals CSF cellular composition in multiple sclerosis but detects no viral RNA.
    Brain. 2024 Jan 5:awae006. doi: 10.1093.
    >> Share

  37. QIN C, Chen M, Dong MH, Yang S, et al
    Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
    Brain. 2024;147:163-176.
    >> Share

  38. JAMANN H, Desu HL, Cui QL, Halaweh A, et al
    ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.
    Brain. 2024;147:147-162.
    >> Share

    December 2023
  39. MARZIALI LN, Hwang Y, Palmisano M, Cuenda A, et al
    p38gamma MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
    Brain. 2023 Dec 21:awad421. doi: 10.1093.
    >> Share

  40. CALLEGARI I, Oechtering J, Schneider M, Perriot S, et al
    Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
    Brain. 2023 Dec 20:awad424. doi: 10.1093.
    >> Share

  41. CREE BAC
    Herpes viral infection and the multiple sclerosis prodrome: is HHV-6A infection a second hit?
    Brain. 2023 Dec 18:awad418. doi: 10.1093.
    >> Share

  42. CLEAVER J, Jeffery K, Klenerman P, Lim M, et al
    The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity.
    Brain. 2023 Dec 13:awad419. doi: 10.1093.
    >> Share

  43. BUTZKUEVEN H, Ponsonby AL, Stein MS, Lucas RM, et al
    Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
    Brain. 2023 Dec 12:awad409. doi: 10.1093.
    >> Share

  44. BAN M, Bredikhin D, Huang Y, Bonder MJ, et al
    Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis.
    Brain. 2023 Dec 1:awad404. doi: 10.1093.
    >> Share

    November 2023
  45. KEDDIE S, Smyth D, Keh RYS, Chou MKL, et al
    Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
    Brain. 2023;146:4562-4573.
    >> Share

    October 2023
  46. GRUT V, Bistrom M, Salzer J, Stridh P, et al
    Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
    Brain. 2023 Oct 31:awad374. doi: 10.1093.
    >> Share

  47. BERNARD HEALEY SA, Giovannoni G, Noyce A, Dobson R, et al
    Impact of multiple sclerosis risk alleles on the plasma proteome.
    Brain. 2023 Oct 18:awad363. doi: 10.1093.
    >> Share

  48. ALLEN NM, O'Rahelly M, Eymard B, Chouchane M, et al
    The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD).
    Brain. 2023;146:4233-4246.
    >> Share

    September 2023
  49. MATSUMOTO Y, Kaneko K, Takahashi T, Takai Y, et al
    Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
    Brain. 2023;146:3938-3948.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016